HCPCS G0276 is officially defined as "Blinded procedure for lumbar stenosis, percutaneous image-guided lumbar decompression (pild) or placebo-control, performed in an approved coverage with evidence development (ced) clinical trial." HCPCS G0276 is referenced in 11 tracked payer policy changes from Independence Blue Cross, Excellus BlueCross BlueShield, and 2 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS G0276 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Independence Blue Cross updated MA11.097f to reflect CPT code changes effective 01/01/2026: CPT 0275T was removed and CPT codes 62330, 62331 were added as experimental/investigational codes for PILD procedures. PILD for lumbar spinal stenosis remains non-covered except when performed in Medicare-approved CED clinical trials using the specified CPT codes with Modifier Q0 or HCPCS G0276.
Independence Blue Cross reissued Policy 11.15.22e to update CPT coding for Percutaneous Image-Guided Lumbar Decompression (PILD). The procedure code 0275T was terminated and replaced with CPT codes 62330 and 62331 effective January 1, 2026. PILD remains classified as experimental/investigational and is NOT covered under IBC commercial plans. Billing teams must use only the new CPT codes (62330/62331) for claim submission; other codes like 63020, 63030, or 63035 do not appropriately represent PILD and should not be used.
Excellus added several new intradiscal procedures to the investigational policy statement in its 06/18/26 annual review. Intradiscal procedures listed in the policy, including annulo-nucleoplasty, intradiscal electrothermal annuloplasty (IDET or IDTA), intradiscal biacuplasty, hydrodiscectomy, and intradiscal injections, are considered investigational. This version is effective October 15, 2026, and every CPT and HCPCS code listed in the policy is marked (E/I) Experimental/Investigational.
Blue Cross and Blue Shield of Nebraska is implementing four new or updated medical policies effective June 1, 2026, all requiring preauthorization: cardiac hemodynamic monitoring for heart failure management (investigational in ambulatory/outpatient settings), image-guided minimally invasive spinal decompression (investigational), intracameral implants for glaucoma/ocular hypertension (bimatoprost and travoprost under specified criteria), and remote electrical neuromodulation for migraine prevention (medically necessary under defined clinical scenarios). Billing teams must implement preauthorization requirements and update systems to reflect these changes before the effective date.
Blue Cross Blue Shield of Nebraska is implementing new prior authorization requirements for four medical policies effective June 1, 2026: cardiac hemodynamic monitoring, image-guided spinal decompression, intracameral implants for glaucoma, and remote electrical neuromodulation for migraines. All of these procedures will require preauthorization and have specific coverage criteria that must be met.
Independence Blue Cross updated MA11.097f to reflect CPT code changes effective 01/01/2026: CPT 0275T was terminated and replaced with CPT codes 62330 and 62331 for percutaneous image-guided lumbar decompression (PILD). PILD remains experimental/investigational and NOT covered except through Coverage with Evidence Development (CED) clinical trials. Billing requires Modifier Q0 with CPT 62330/62331 or HCPCS G0276 for approved CED studies.
Independence Blue Cross has reissued Policy 11.15.22e to update CPT codes for Percutaneous Image-Guided Lumbar Decompression (PILD). The outdated code 0275T has been removed and replaced with new specific codes 62330 and 62331, effective 01/01/2026. PILD remains classified as experimental/investigational and is not covered under commercial plans.
Independence Blue Cross Medicare Advantage has reissued policy MA11.097e regarding Percutaneous Image-Guided Lumbar Decompression (PILD) for spinal stenosis, clarifying that the procedure remains experimental/investigational and NOT covered except through Coverage with Evidence Development (CED) clinical trials. Billing teams must ensure claims for PILD procedures in CED trials use the correct modifier (Q0) and appropriate procedure codes (62330, 62331, or G0276) to avoid denials.
Independence Blue Cross has reissued Policy 11.15.22d (now superseded by 11.15.22e as of 04/02/2025) confirming that Percutaneous Image-Guided Lumbar Decompression (PILD) for spinal stenosis remains experimental/investigational and NOT COVERED under commercial medical benefits. No coverage policy changes have occurred; this is a routine annual reissuance reaffirming the existing non-coverage position. Billing teams must continue to deny claims for CPT codes 62330 and 62331 when submitted for PILD procedures.
BCBSAZ covers usual and customary (standard, non-investigational) services associated with an eligible clinical trial under non-grandfathered group and individual plans, on and off exchange. Eligibility requires documentation that the individual or provider notified BCBSAZ of the clinical trial enrollment and that participation in any phase is voluntary, and the covered services include laboratory and radiology services, physician services for consultations, medical assessments and follow-up visits, medical diagnostic and/or surgical procedures, and FDA approved medications that are approved for the requested indication or are off-label uses recognized as safe and effective by the NCCN Drugs & Biologics Compendium with Categories of Evidence and Consensus of 1 or 2A. Investigational medications or devices, items or services that are the subject of the clinical study or provided solely for data collection, costs of managing the research, and non-health services such as travel, transportation and lodging are not eligible for coverage.
BCBSAZ covers usual and customary (standard, non-investigational) services associated with an eligible cancer clinical trial conducted within Arizona, and these services include laboratory and radiology services, physician services for consultations, medical assessments and follow-up visits, medical diagnostic and/or surgical procedures, and FDA approved medications that are approved for the requested indication or are off-label uses recognized as safe and effective by the NCCN Drugs & Biologics Compendium with Categories of Evidence and Consensus of 1 or 2A. Eligibility requires documentation that the individual or provider notified BCBSAZ of the cancer clinical trial enrollment, that the services are directly associated with the trial, and that participation in any phase is voluntary. This criteria is not applicable to non-grandfathered group and individual plans on and off exchange effective or renewed on or after January 1, 2014, which are addressed in Evidence-Based Criteria AP108.
Watch G0276
Get one email when a payer policy names G0276, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.
See every payer rule for G0276
Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for G0276 in one place.
Get alerts for changes like this
Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.